We observed that suramin inhibited renal TGF-β1– mediated activation of SMAD-3 in the 9 and 17 week diabetic mice, supporting our previous finding of the anti-fibrotic potential of suramin in early hyperglycemia-induced kidney injury. The gene discussed is SMAD3; the disease is Hyperglycemia.